General Practice · Highland Park, MI
NPI
1700962446
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
13111 Woodward Ave
Highland Park, MI, 48203
Phone (313) 866-6666
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
623 services
Medicare patients, 2024
133
Average age 62
Drug cost, 2024
$2.6M
29,990 prescriptions
Company payments, 2025
$650
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sanjay N Lakhani was code 99214 (office e&m - established), 385 times for 127 patients. In total Sanjay N Lakhani billed 623 services in 12 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 385 | 127 | $90.18 | $35K |
| 99213 Office E&M - Established | Office | 74 | 49 | $56.35 | $4,170 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 66 | 66 | $129.52 | $8,548 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 24 | 24 | $165.01 | $3,960 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $32.71 | $720 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 19 | 19 | $164.94 | $3,134 |
| 90662 Vaccine Product | Office | 15 | 15 | $81.82 | $1,227 |
By year: 2022 $74K for 1,123 services; 2023 $76K for 849 services; 2024 $59K for 623 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sanjay N Lakhani prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,312 prescriptions and refills. In total Sanjay N Lakhani wrote 29,990 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,312 | 1,606 | 210 | $5,388 |
| Montelukast Sodium Generic | 1,309 | 1,526 | 248 | $5,746 |
| Amlodipine Besylate Generic | 1,175 | 1,515 | 196 | $2,969 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 779 | 779 | 115 | $7,443 |
| Metoprolol Succinate Generic | 717 | 883 | 109 | $4,441 |
| Pantoprazole Sodium Generic | 694 | 803 | 109 | $3,359 |
| Losartan Potassium Generic | 671 | 905 | 109 | $2,992 |
| Lisinopril Generic | 556 | 688 | 88 | $1,610 |
| Tizanidine Hcl Generic | 544 | 652 | 103 | $2,781 |
| Potassium Chloride Generic | 524 | 616 | 90 | $4,038 |
| Omeprazole Generic | 513 | 607 | 89 | $3,589 |
| Tamsulosin Hcl Generic | 497 | 600 | 89 | $2,378 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 478 | 480 | 102 | $307K |
| Simvastatin Generic | 431 | 689 | 80 | $1,415 |
| Farxiga Dapagliflozin Propanediol | 413 | 427 | 73 | $243K |
Brand drugs: 4,391 claims; generic drugs: 24,972 claims; opioid claims: 843.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sanjay N Lakhani $650 ($650 in general payments such as food, travel and fees) from 8 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $210.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 12 | $210 |
| Novo Nordisk Inc NVO | 9 | $148 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $104 |
| GlaxoSmithKline, LLC. GSK | 4 | $81.58 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $50.55 |
| Gilead Sciences, Inc. GILD | 1 | $23.2 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $20.9 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $11.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.